Roche’s PiaSky approved in the EU as the first monthly subcutaneous treatment for people with PNH Read more
Enhertu approved in China for patients with previously treated HER2-positive advanced or metastatic gastric cancer Read more
GSK’s Jemperli (dostarlimab) plus chemotherapy approved in Singapore as the first frontline immuno-oncology treatment for dMMR/MSI-H primary advanced or recurrent endometrial cancer Read more
Daiichi Sankyo and Merck Enter into Global Development and Commercialization Agreement for MK-6070 Read more
Sangamo Therapeutics Announces Global Epigenetic Regulation and Capsid Delivery License Agreement with Genentech to Develop Novel Genomic Medicines for Neurodegenerative Diseases Read more
Roche closes acquisition of LumiraDx’s Point of Care technology to expand access to diagnostic testing in primary care Read more
Boehringer Ingelheim secures novel immune checkpoint inhibitor with acquisition of Nerio Therapeutics Read more
Novartis Scemblix granted FDA Priority Review for the treatment of adults with newly diagnosed CML Read more